ELAST Technologies, Inc.'s Founder Dr. Robert D. Milne Once Again Teams With David B. Phillips Inventor of the `Ear Thermometer' to Refine ELAST's Non-Invasive Allergy Testing System

Business Wire, Oct 19, 1998

LAS VEGAS--(BUSINESS WIRE)--Oct. 19, 1998--ELAST Technologies, Inc.'s (OTC-Bulletin Board:ETSG) David B. Phillips and Thomas Krucker, President, will attend Discovery Expo, sponsored by The Investment Reporter, Investor's Business Daily, & Business Wire on October 20, 1998 from Noon until 8 o'clock at the New York Hilton, 6th Avenue & 53rd Street.

A prototype of the ELAST testing system will be demonstrated for the investment community at Tuesday's Discovery Expo.

Current blood and skin-prick testing cost patients and insurers billions of dollars each year with an accuracy range of only 60-80% and the associated expense of time and disposal protocols and regulations. The non-invasive ELAST testing system and management software is expected to detect allergies as well as food and chemical sensitivities at a significantly greater accuracy rate -- instantly and non-invasively.

Mr. Phillips' career in medical technology began with the development of his GST system for the early detection of breast cancer in 1976. That non-invasive system was clinically tested and proven to be 94% accurate by Memorial Sloan- Kettering Cancer Center in 1978 and his testing device found additional applications in monitoring non-malignant breast disease.

Mr. Phillips currently has a breakthrough non-invasive breast cancer detection system with Phillips Engineering and has developed an electronic device to relieve pain and help in the rehabilitation of patients who have undergone coronary by-pass surgery. Yet David Phillips is perhaps best known for his most familiar invention, the ear thermometer, which has changed the way the world takes temperatures.

Thomas Krucker, president of ELAST explained that he believes that ELAST "will change forever the way people are tested for allergies and food and chemical sensitivities by eliminating the pain and significantly reduce the delay and cost associated with the current industry standard diagnostic tools --- the RAST and cytotoxic tests." Mr. Krucker is confident that Dr. Milne's and Mr. Phillips' collaboration will result in the refinement of the ELAST testing system.

The testing unit is under final development. In its current stage it reflects the allergic reaction but requires refinement towards easier readability. Computer enhancement is expected to clean up the signal processing and the marketability of the system and the software is predicated upon this refinement.